518O Overall survival results from ARIEL4: A phase III study assessing rucaparib vs chemotherapy in patients with advanced, relapsed ovarian carcinoma and a deleterious BRCA1/2 mutation

A.M. Oza, A.S. Lisyanskaya, A.A. Fedenko, A.C. de Melo, Y. Shparik, Igor Bondarenko, N. Colombo, D. Lorusso, D. Cibula, R.L. Póka, A. Oaknin, T. Safra, Beata Maćkowiak-Matejczyk, L. Ma, D. Thomas, K.K. Lin, K. McLachlan, S. Goble, R. Kristeleit